BioSpace News Archive

US Digestive Health, one of the largest gastroenterology practices in the United States, announced the addition of nine physicians this summer to its continuously expanding footprint.

The Foundation for the National Institutes of Health has awarded its sixth annual Trailblazer Prize for Clinician-Scientists to Vinod Balachandran, M.D., at Memorial Sloan Kettering Cancer Center, for his groundbreaking research on immunotherapies for pancreatic cancer.

Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has granted marketing authorization for ABRYSVO™, the company’s bivalent respiratory syncytial virus (RSV) prefusion F (RSVpreF) vaccine, to help protect both infants through maternal immunization and older adults.

Alafair Biosciences announced that it has been recognized as No. 1249 on the 2023 Inc. 5000, the annual list of the fastest-growing private companies in America, and No. 23 among Health Products.

NKGen Biotech, Inc. (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic, and CAR-NK natural killer (“NK”) cell therapies, today announced the first patient has been dosed in a Phase I, multi-center, open-label, dose-escalation study evaluating its cryopreserved investigational allogeneic blood-derived NK cell therapy (“SNK02”).

Zhongchao Inc. announced it has achieved a milestone of serving over 10,000 breast cancer patients in China with comprehensive disease management services since 2021.

Charles River Laboratories International, Inc., announced a High Quality plasmid manufacturing collaboration with Fondazione Telethon.

BostonGene, NEC Corporation and Japan Industrial Partners announced the formation of BostonGene Japan Inc., a Tokyo-based joint venture aimed at advancing personalized medicine and dramatically improving patient outcomes.

BioSig Technologies, Inc. is providing an update since the launch of BioSig’s established technology team with external partners and collaborators to advance the research and development of an artificial intelligence medical device platform.

Octave® Bioscience, Inc. was honored in Fast Company’s Innovation by Design Awards for 2023 in the Health category.